# Efficacy and Safety Study of Nimodipine to Prevent Mild Cognitive Impairment After Acute Ischemic Strokes

> **NCT01220622** · PHASE4 · UNKNOWN · sponsor: **Ministry of Science and Technology of the People´s Republic of China** · enrollment: 656 (estimated)

## Conditions studied

- Stroke
- Mild Cognitive Impairment

## Interventions

- **DRUG:** Nimodipine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01220622
- **Lead sponsor:** Ministry of Science and Technology of the People´s Republic of China
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** 2012-04
- **Final completion:** 2012-07
- **Target enrollment:** 656 (ESTIMATED)
- **Last updated:** 2010-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01220622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01220622, "Efficacy and Safety Study of Nimodipine to Prevent Mild Cognitive Impairment After Acute Ischemic Strokes". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01220622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*